rs781369203
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_020361.5(CPA6):c.757T>G(p.Trp253Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W253R) has been classified as Uncertain significance.
Frequency
Consequence
NM_020361.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPA6 | NM_020361.5 | c.757T>G | p.Trp253Gly | missense_variant | 8/11 | ENST00000297770.10 | |
ARFGEF1-DT | NR_136224.1 | n.694-7116A>C | intron_variant, non_coding_transcript_variant | ||||
CPA6 | XM_017013646.2 | c.313T>G | p.Trp105Gly | missense_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPA6 | ENST00000297770.10 | c.757T>G | p.Trp253Gly | missense_variant | 8/11 | 1 | NM_020361.5 | P1 | |
CPA6 | ENST00000518549.1 | n.971T>G | non_coding_transcript_exon_variant | 8/8 | 1 | ||||
CPA6 | ENST00000479862.6 | c.*353T>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/8 | 1 | ||||
CPA6 | ENST00000638254.1 | c.*353T>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/10 | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461368Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727012
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Febrile seizures, familial, 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2020 | In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a CPA6-related disease. This sequence change replaces tryptophan with glycine at codon 253 of the CPA6 protein (p.Trp253Gly). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and glycine. - |
Familial temporal lobe epilepsy 5;C3280734:Febrile seizures, familial, 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Aug 27, 2021 | The inherited c.757T>G, p.Trp253Gly missense variant in CPA6 has not been reported in the literature for CPA6-related disorders. This variant is absent in the gnomAD v3.1.1 database, suggesting it is not a common benign variant in the populations represented in this database. In silico tools predicts conflicting interpretations of pathogenicity. The variant resides at Zinc carboxypeptidase domain. Based on the available evidence, the missense variant c.757T>G,p.Trp253Gly in the CPA6 gene is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at